AAAAAA
Results: 1-25/53
Authors:
REESINK HW
ENGELFRIET CP
VRIELINK H
KRUSIUS T
LANKINEN M
FLANAGAN P
BARBARA J
GILL P
DODD RY
BUSCH MP
PRATI D
MOZZI F
SIRCHIA G
DIEKAMP U
EPSTEIN JS
TABOR E
MARTINVEGA C
HERNANDEZ JM
Citation: Hw. Reesink et al., CONSEQUENCES OF NUCLEIC-ACID AMPLIFICATION TESTING FOR BLOOD-TRANSFUSION CENTERS, Vox sanguinis, 74(4), 1998, pp. 263-270
Authors:
VANDENBURG PJM
VRIELINK H
REESINK HW
Citation: Pjm. Vandenburg et al., DONOR SELECTION - THE EXCLUSION OF HIGH-RISK DONORS, Vox sanguinis, 74, 1998, pp. 499-502
Authors:
VRIELINK H
VANDERMEER CBM
REESINK HW
Citation: H. Vrielink et al., EVALUATION OF 4 ANTI-HTLV-I AND ANTI-HTLV-II ASSAYS, Transfusion, 38(10), 1998, pp. 189-189
Authors:
VANDENBURG PJM
VRIELINK H
REESINK HW
Citation: Pjm. Vandenburg et al., TIME-INTERVAL OF 5 YEARS BETWEEN HTLV-I INFECTION AND THE APPEARANCE OF ANTIBODIES IN A REPEAT BLOOD-DONOR, Transfusion, 38(10), 1998, pp. 191-191
Authors:
VRIELINK H
HABIBUW MR
SCHULLER M
REESINK HW
Citation: H. Vrielink et al., SENSITIVITY AND SPECIFICITY OF 2 ANTI-HIV-1 2 ELISAS/, Transfusion, 38(10), 1998, pp. 199-199
Authors:
VRIELINK H
HABIBUW MR
SCHULLER M
REESINK HW
Citation: H. Vrielink et al., SENSITIVITY AND SPECIFICITY OF 2 ANTI-HIV-1 2(O) ELISAS OF MUREX/, Transfusion, 38(10), 1998, pp. 203-203
Authors:
VRIELINK H
HABIBUW MR
SCHULLER M
REESINK HW
Citation: H. Vrielink et al., RELATIVE SENSITIVITY OF 3 ANTI-HIV-1 2 ELISAS FROM MUREX AND ORTHO/, Transfusion, 38(10), 1998, pp. 204-204
Authors:
HABIBUW MR
VRIELINK H
REESINK HW
BELD M
Citation: Mr. Habibuw et al., EVALUATION OF NUCLEIC-ACID AMPLIFICATION TECHNOLOGY (NAT) EFFICIENCY OF HEPATITIS-C VIRUS (HCV) IN POOL SCREENING SYSTEMS, Transfusion, 38(10), 1998, pp. 206-206
Authors:
VRIELINK H
HABIBUW MR
SCHULLER M
REESINK HW
Citation: H. Vrielink et al., EVALUATION OF A NEW HBSAG ELISA, Transfusion, 38(10), 1998, pp. 220-220
Authors:
VRIELINK H
REESINK HW
PETERSON JE
KOCHESKY R
LEE S
Citation: H. Vrielink et al., PEPTIDE ANALYSIS IN NS5 ONLY RIBA INDETERMINATE SERA, Transfusion, 38(10), 1998, pp. 347-347
Authors:
VRIELINK H
ZAAIJER HL
REESINK HW
Citation: H. Vrielink et al., THE CLINICAL RELEVANCE OF HTLV TYPE-I AND TYPE-II IN TRANSFUSION MEDICINE, Transfusion medicine reviews, 11(3), 1997, pp. 173-179
Authors:
VRIELINK H
VANDERPOEL CL
Citation: H. Vrielink et Cl. Vanderpoel, WHAT ARE THE CONSEQUENCES OF INDETERMINATE RESULTS IN CONFIRMATORY TESTS FOR ANTIBODIES AGAINST TRANSMISSIBLE VIRUSES, Vox sanguinis, 73(2), 1997, pp. 104-104
Authors:
VRIELINK H
ZAAIJER HL
CUYPERS HTM
VANDERPOEL CL
WOERDEMAN M
LELIE PN
WINKEL C
REESINK HW
Citation: H. Vrielink et al., EVALUATION OF A NEW HTLV-I II POLYMERASE CHAIN-REACTION/, Vox sanguinis, 72(3), 1997, pp. 144-147
Authors:
VRIELINK H
REESINK HW
ZAAIJER HL
SCHOLTEN E
KREMER LCM
CUYPERS HTM
LELIE PN
VANOERS MHJ
VANDERPOEL CL
Citation: H. Vrielink et al., LOOK-BACK OF ANTI-HCV ELISA-POSITIVE, HCV-RNA PCR-NEGATIVE DONORS ANDRECIPIENTS OF THEIR BLOOD PRODUCTS, Vox sanguinis, 72(2), 1997, pp. 67-70
Authors:
VRIELINK H
REESINK HW
Citation: H. Vrielink et Hw. Reesink, ANALYSIS OF THE SENSITIVITY OF REAGENTS BY TESTING PANELS OF DILUTIONS OF POSITIVE SERA VERSUS PANELS OF WEAKPOSITIVE NATIVE SERA, Transfusion, 37(9), 1997, pp. 103-103
Authors:
VRIELINK H
VANDERMEER CBM
REESINK HW
Citation: H. Vrielink et al., EVALUATION OF 3 ANTI-HTLV-I AND ANTI-HTLV-II ASSAYS - ABBOTT, MUREX AND ORGANON-TEKNIKA, Transfusion, 37(9), 1997, pp. 186-186
Authors:
VRIELINK H
REESINK HW
HERMUS MC
CUYPERS HTM
LELIE PN
Citation: H. Vrielink et al., DIFFERENCE IN HGV INFECTION IN BLOOD-DONORS BETWEEN A LARGE CITY AND RURAL DISTRICTS IN A WEST-EUROPEAN COUNTRY, Transfusion, 37(9), 1997, pp. 187-187
Authors:
VRIELINK H
REESINK HW
LELIE PN
Citation: H. Vrielink et al., RELATIVE SENSITIVITY OF 4 ANTI-HTLV-I AND HTLV-II ELISAS - ABBOTT, MUREX, ORGANON-TEKNIKA AND ORTHO, Transfusion, 37(9), 1997, pp. 197-197
Authors:
VRIELINK H
SCHULLER M
REESINK HW
Citation: H. Vrielink et al., EVALUATION OF THE ORTHO HCV-3.0 ELISA TEST SYSTEM WITH ENHANCED SAVE, Transfusion, 37(9), 1997, pp. 211-211
Authors:
VANDENBURG PJM
VRIELINK H
REESINK HW
Citation: Pjm. Vandenburg et al., HIV WINDOW INFECTION BY AN ANTI-HIV AND HIV-AG NEGATIVE BLOOD PRODUCT- A CASE-REPORT, Transfusion, 37(9), 1997, pp. 212-212
Authors:
VRIELINK H
SCHULLER M
REESINK HW
Citation: H. Vrielink et al., SENSITIVITY OF A NEW ANTI-HTLV-I AND ANTI-HTLV-II ELISA, Transfusion, 37(9), 1997, pp. 225-225
Authors:
VRIELINK H
REESINK HW
VANDENBURG PJM
ZAAIJER HL
CUYPERS HTM
LELIE PN
VANDERPOEL CL
Citation: H. Vrielink et al., PERFORMANCE OF 3 GENERATIONS OF ANTI-HEPATITIS-C VIRUS ENZYME-LINKED IMMUNOSORBENT ASSAYS IN DONORS AND PATIENTS, Transfusion, 37(8), 1997, pp. 845-849
Authors:
VRIELINK H
ZAAIJER HL
VANDERPOEL CL
QUAN S
CUYPERS HTM
RIOS M
LELIE PN
POLITO A
SRA K
DINELLO R
PICHUANTES S
LARSON D
REESINK HW
Citation: H. Vrielink et al., NEW STRIP IMMUNOBLOT FOR THE CONFIRMATION OF HTLV-I II INFECTION/, Vox sanguinis, 70(2), 1996, pp. 114-116
Authors:
VRIELINK H
REESINK HW
ZAAIJER HL
VANDERPOEL CL
CUYPERS HTM
LELIE PN
Citation: H. Vrielink et al., SENSITIVITY AND SPECIFICITY OF 4 ASSAYS TO DETECT HUMAN T-LYMPHOTROPIC VIRUS TYPE-I OR TYPE-I II ANTIBODIES/, Transfusion, 36(4), 1996, pp. 344-346
Authors:
VRIELINK H
VANDERPOEL CL
REESINK HW
Citation: H. Vrielink et al., NEW SYNTHETIC IMMUNOBLOT FOR CONFIRMATION OF HTLV-I II INFECTION/, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 173-173